USD 3.34
(0.6%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -208.54 Million USD | 43.78% |
2022 | -370.92 Million USD | 41.77% |
2021 | -636.99 Million USD | -587.1% |
2020 | -92.7 Million USD | 49.4% |
2019 | -183.19 Million USD | 1.4% |
2018 | -185.79 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -22.7 Million USD | 65.42% |
2024 Q2 | 7.18 Million USD | 131.66% |
2023 Q3 | -41.46 Million USD | -43.95% |
2023 Q2 | -28.8 Million USD | 60.32% |
2023 FY | -208.54 Million USD | 43.78% |
2023 Q1 | -72.6 Million USD | 32.25% |
2023 Q4 | -65.66 Million USD | -58.34% |
2022 Q3 | -73.91 Million USD | 28.05% |
2022 Q2 | -102.72 Million USD | -17.67% |
2022 Q1 | -87.3 Million USD | 53.26% |
2022 Q4 | -107.16 Million USD | -44.98% |
2022 FY | -370.92 Million USD | 41.77% |
2021 Q1 | -119.08 Million USD | -76.09% |
2021 FY | -636.99 Million USD | -587.1% |
2021 Q4 | -186.79 Million USD | -25.15% |
2021 Q3 | -149.25 Million USD | 17.93% |
2021 Q2 | -181.86 Million USD | -52.71% |
2020 Q3 | -21.61 Million USD | -193.3% |
2020 Q2 | 23.17 Million USD | 187.01% |
2020 Q1 | -26.63 Million USD | -150940.78% |
2020 FY | -92.7 Million USD | 49.4% |
2020 Q4 | -67.62 Million USD | -212.84% |
2019 Q2 | -44.28 Million USD | 0.0% |
2019 Q4 | -17.63 Thousand USD | 99.94% |
2019 Q3 | -30.85 Million USD | 30.33% |
2019 Q1 | -44.28 Million USD | 0.0% |
2019 FY | -183.19 Million USD | 1.4% |
2018 FY | -185.79 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Alignment Healthcare, Inc. | -127.81 Million USD | -63.157% |
NewGenIvf Group Limited | 42.24 Thousand USD | 493784.011% |